Work

621 Pl02.05 Long-term Treatment of Patients With Eosinophilic Gastritis And/or Eosinophilic Duodenitis With Lirentelimab, a Monoclonal Antibody Against Siglec-8

Year: 2021

Type: article

Source: Diseases of the Esophagus

DOI: 10.1093/dote/doab052.621

Authors: Kathryn Peterson, Mirna Chehade, Joseph Murray, Gary Falk, Nirmala Gonsalves, Robert Genta, Marc Rothenberg, Adam Bledsoe, Sandy Durrani, Michael Vaezi, Camilla Shaw, Henrik Rasmussen, Bhupinder Singh, Alan Chang, Amol Kamboj, Ikuo Hirano, Evan Dellon

Institutions: University of Utah, Icahn School of Medicine at Mount Sinai, Mayo Clinic, University of Pennsylvania, Northwestern University, Baylor College of Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Vanderbilt University, Allakos (United States), University of North Carolina at Chapel Hill

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3199711690

FWCI:

Cites:

Cited by:

Related to: 10